Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1541
2021 675
Text availability
Article attribute
Article type
Publication date

Search Results

2,216 results
Results by year
Filters applied: . Clear all
Page 1
Testing the association between blood type and COVID-19 infection, intubation, and death.
Zietz M, Zucker J, Tatonetti NP. Zietz M, et al. medRxiv. 2020 Apr 11:2020.04.08.20058073. doi: 10.1101/2020.04.08.20058073. Preprint. medRxiv. 2020. PMID: 32511586 Free PMC article. Updated.
The rapid global spread of the novel coronavirus SARS-CoV-2 has strained existing healthcare and testing resources, making the identification and prioritization of individuals most at-risk a critical challenge. A recent study of patients in Chin …
The rapid global spread of the novel coronavirus SARS-CoV-2 has strained existing healthcare and testing
Safety, Tolerability, and Immunogenicity of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
Yuan P, Ai P, Liu Y, Ai Z, Wang Y, Cao W, Xia X, Zheng JC. Yuan P, et al. medRxiv. 2020 Nov 4:2020.11.03.20224998. doi: 10.1101/2020.11.03.20224998. Preprint. medRxiv. 2020. PMID: 33173896 Free PMC article.
We aimed to summarize reliable medical evidence by the meta-analysis of all published clinical trials that investigated the safety, tolerability, and immunogenicity of vaccine candidates against coronavirus disease 2019 (COVID-19), caused by severe
We aimed to summarize reliable medical evidence by the meta-analysis of all published clinical trials that investigated the safety, tolerabi …
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study.
Walsh EE, Frenck R, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Thompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, Sahin U, Gruber WC. Walsh EE, et al. medRxiv. 2020 Aug 20:2020.08.17.20176651. doi: 10.1101/2020.08.17.20176651. Preprint. medRxiv. 2020. PMID: 32839784 Free PMC article. Updated.
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease, coronavirus disease 2019 (COVID-19), have spread to millions of people globall …
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infe …
Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19.
Patterson BK, Seethamraju H, Dhody K, Corley MJ, Kazempour K, Lalezari JP, Pang AP, Sugai C, Francisco EB, Pise A, Rodrigues H, Ryou M, Wu HL, Webb GM, Park BS, Kelly S, Pourhassan N, Lelic A, Kdouh L, Herrera M, Hall E, Aklin E, Ndhlovu L, Sacha JB. Patterson BK, et al. medRxiv. 2020 May 5:2020.05.02.20084673. doi: 10.1101/2020.05.02.20084673. Preprint. medRxiv. 2020. PMID: 32511656 Free PMC article.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is now pandemic with nearly three million cases reported to date. .
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative a
COVID-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacity.
Pace RM, Williams JE, Järvinen KM, Belfort MB, Pace CD, Lackey KA, Gogel AC, Nguyen-Contant P, Kanagaiah P, Fitzgerald T, Ferri R, Young B, Rosen-Carole C, Diaz N, Meehan C, Caffe B, Sangster MY, Topham DJ, McGuire MA, Seppo A, McGuire MK. Pace RM, et al. medRxiv. 2020 Sep 18:2020.09.16.20196071. doi: 10.1101/2020.09.16.20196071. Preprint. medRxiv. 2020. PMID: 32995804 Free PMC article.
All milk contained SARS-CoV-2-specific IgA and IgG, and levels of anti-RBD IgA correlated with SARS-CoV-2 neutralization. ...Importantly, milk produced by infected mothers is a source of anti-SARS-CoV-2 IgA and IgG an …
All milk contained SARS-CoV-2-specific IgA and IgG, and levels of anti-RBD IgA correlated with SARS-CoV- …
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques.
van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato V, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Pérez-Pérez L, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ. van Doremalen N, et al. bioRxiv. 2020 May 13:2020.05.13.093195. doi: 10.1101/2020.05.13.093195. Preprint. bioRxiv. 2020. PMID: 32511340 Free PMC article. Updated.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in December 2019(1,2) and is responsible for the COVID-19 pandemic(3). ...Here, we show that the adenovirus-vectored vac
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in Decem
Effect of social distancing on COVID-19 incidence and mortality in the US.
VoPham T, Weaver MD, Hart JE, Ton M, White E, Newcomb PA. VoPham T, et al. medRxiv. 2020 Jun 12:2020.06.10.20127589. doi: 10.1101/2020.06.10.20127589. Preprint. medRxiv. 2020. PMID: 32587998 Free PMC article.
Social distancing policies were implemented in most US states as a containment strategy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The effectiveness of these policy interventions on morbidit …
Social distancing policies were implemented in most US states as a containment strategy against severe acute respiratory
COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning.
Ong E, Wong MU, Huffman A, He Y. Ong E, et al. bioRxiv. 2020 Mar 21:2020.03.20.000141. doi: 10.1101/2020.03.20.000141. Preprint. bioRxiv. 2020. PMID: 32511333 Free PMC article. Updated.
To ultimately combat the emerging COVID-19 pandemic, it is desired to develop an effective and safe vaccine against this highly contagious disease caused by the SARS-CoV-2 coronavirus. ...The nsp3 was found to be more conserved among S
To ultimately combat the emerging COVID-19 pandemic, it is desired to develop an effective and safe vaccine against this highl …
COVID-19 neutralizing antibodies predict disease severity and survival.
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB. Garcia-Beltran WF, et al. medRxiv. 2020 Oct 20:2020.10.15.20213512. doi: 10.1101/2020.10.15.20213512. Preprint. medRxiv. 2020. PMID: 33106822 Free PMC article. Updated.
While anti-RBD IgG levels generally correlated with neutralization titer, quantitation of neutralization potency revealed that high potency was a predictor of survival. In addition to neutralization of wild-type SARS-CoV-2, patient sera were also able to neut …
While anti-RBD IgG levels generally correlated with neutralization titer, quantitation of neutralization potency revealed that high potency …
Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19.
Dogan M, Kozhaya L, Placek L, Gunter CL, Yigit M, Hardy R, Plassmeyer M, Coatney P, Lillard K, Bukhari Z, Kleinberg M, Hayes C, Arditi M, Klapper E, Merin N, Liang BT, Gupta R, Alpan O, Unutmaz D. Dogan M, et al. medRxiv. 2020 Jul 8:2020.07.07.20148106. doi: 10.1101/2020.07.07.20148106. Preprint. medRxiv. 2020. PMID: 32676617 Free PMC article. Updated.
Development of antibody protection during SARS-CoV-2 (CoV-2) infection is a pressing question for public health and for vaccine development. ...Further, subjects who donated plasma further out from the diagnosis of COVID-19 appeare …
Development of antibody protection during SARS-CoV-2 (CoV-2) infection is a pressing question for public …
2,216 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page